Shares of Salesforce (CRM) rose about 2% premarket on Thursday after the company’s results and outlook drew positive views from analysts.
Wedbush kept its Outperform rating and $375 price target on the shares of the software giant.
“CRM reported its FY3Q26 results with the top-line coming in line with Street expectations while seeing a significant bottom-line beat with better-than-expected FY4Q26 top-line guidance as the company continues to invest aggressively in its Agentforce strategy to reaccelerate growth,” said analysts led by Dan Ives.
The analysts added that Salesforce provided fourth quarter fiscal 2026 guidance which came in above Street estimates on the top-line while meeting the Street’s EPS estimate as the company balances investments into growth with margin expansion and free cash flow, or FCF, generation.
“This was a step in the right direction for CRM with a long way to go as the Agentforce strategy builds incremental momentum with a strong pipeline to capitalize on while balancing investments into growth initiatives with bottom-line expansion over the coming quarters,” said Ives and his team.
Evercore maintained its Outperform rating but lowered the price target on the stock to $340 from $360.
Analysts led by Kirk Materne said Salesforce delivered “solid” fiscal third quarter results, adding that current remaining performance obligations, or cRPO, growth of 11%/11% in constant currency, or cc, versus Evercore/Street estimates of ~10.2% or 9% in cc was a solid nearly 200 basis points, or bps, beat in cc aided modestly by early renewals, but the bulk was driven by strong bookings.
“Clearly, there is risk that CRM shares remain stuck in the mud, but we see the upside materially outweighing the downside. Following a solid F3Q and building Agentforce momentum, we are adding CRM to our top five ideas for 2026 along with Microsoft (MSFT), Intuit (INTU), Oracle (ORCL), and Snowflake (SNOW),” said Materne and his team.
Morgan Stanley kept its Overweight rating with a $405 price target on Salesforce’s stock.
“A bigger beat and slight acceleration in cRPO, coupled with an impressive ramp in Agentforce metrics, reinforce the theme of building momentum we heard at the Analyst Day. While it may take a few more data points for a skeptical investor base to come on board, at 13X EV/CY27 FCF, we are buyers here,” said analysts led by Keith Weiss.
Wells Fargo maintained its Equal Weight rating on the shares with a $265 price target.
“Our estimates move higher mostly to incorporate INFA acquisition. Organic numbers largely unchanged, keeping us balanced until we gain more evidence to corroborate the anticipated Agentforce-led acceleration in 12-18 months,” said analysts Michael Turrin and his team.